|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Alterations in photochemical efficiency of photosystem Ⅱ in wheat plant on hot summer day 显示文摘 | Sonal M Anjana J | 2014 | Physi- ology and Molecular Biology of Plants2014，20，4： | 1 |
| 2 | Liquefactions of plant sources from starch 显示文摘 | Desai Sonal Thalore I M Sarawade B D Devi Surekha | 2000 | Polymer Engineering and Science2000，40，： | 1 |
| 3 | Effect of SP500263, a novel, potent antiestrogen on breast cancer cells and in xenograft models显示文摘 | Helen B Sonal D Leah M | 2002 | Cancer Res2002，62，5： | 1 |
| 4 | Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor Suppression显示文摘 | Maria Genander Michael M. Halford Nan-Jie Xu Malin Eriksson Zuoren Yu Zhaozhu Qiu Anna Martling Gedas Greicius Sonal Thakar Timothy Catchpole Michael J. Chumley Sofia Zdunek Chenguang Wang Torbj?rn Holm Stephen P. Goff Sven Pettersson Richard G. Pestell M | 2009 | Cell2009，，4： | 1 |
| 5 | Structure property relationship in polyurethane elastomers containing starch as a crosslinker显示文摘 | Desai Sonal Thakore I M Sarawade B D Surekha Devi | 2000 | Polym Eng Sci2000，40，5： | 1 |
| 6 | Trisomy 8 in leukemia:A GCRI experience显示文摘 | Sonal R Bakshi Manisha M | 2012 | Indian J Hum Genet2012，18，1： | 1 |
| 7 | Structure properly relationship in polyurethane elaatorners containing starch as a crosslinker 显示文摘 | Desai Sonal Thakore I M Sarawade B D Slrekha Dfvl | 2000 | Polyrn Eng Sci2000，40，5： | 1 |
| 8 | Structure - Property Relationship in Polyurethane Elastomers ContainingStarch as a Crosslinker显示文摘 | DESAI SONAL’THAKORE I M’SARAWADE B D SUREKHA DEVI | 2000 | Polym Eng Sci2000，40，5： | 1 |
| 9 | Thermomechanical Properties and Morphology of Interpenetrating Networks of Polyurethane-poly (methyl methacrylate) 显示文摘 | Sonal Desai I M Thakore Anthony Brennan | 2002 | Journal of Applied Polymer Science2002，83，7： | 1 |
| 10 | Topical application/formulation of probiotics:will it be a novel treatment approach for diabetic foot ulcer显示文摘 | Sonal Sekhar M Unnikrishnan M K Vijayanarayana K | 2014 | Med Hypotheses2014，82，1： | 1 |
| 11 | Effect of polyols and diisocyanates on thermo-mechanical and morphological properties ofpolyurethanes显示文摘 | Desai Sonal Thakore I M Sarawade B D | 2000 | European Polymer Journal2000，36，： | 1 |
| 12 | Structure- property relationship in polyurethane elastomers containing starch as a crosslinker显示文摘 | Desai Sonal Thakore I M Sarawade B D | 2000 | Polym Eng Sci2000，40，12： | 1 |
| 13 | Direct continuous hydrothermal synthesis of high surface area nanosized titania显示文摘 | Zhice Zhang Sonal Brown Josephine B M | 2009 | Journal of Alloys and Compounds2009，，476： | 1 |
| 14 | Ketal ization of ketone with diols catalyzed by metal( Ⅳ )phosphates as solid acid catalysts显示文摘 | Sonal M Patel Uma V Chudasama Pralhad A Ganeshpure | 2003 | Journal of Molecular Catalysis A: Chemical2003，，194： | 1 |
| 15 | Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy 显示文摘 | Sonal C Michael M Daniele T | 2012 | J Clin Aesthet Dermatol2012，5，12： | 1 |
| 16 | Transitions of care across hospital settings in patients with inflammatory bowel disease显示文摘BACKGROUND Inflammatory bowel disease(IBD) is a chronic, inflammatory disorder characterised by both intestinal and extra-intestinal pathology. Patients may receive both emergency and elective care from several providers, often in different hospital settings. Poorly managed transitions of care between providers can lead to inefficiencies in care and patient safety issues. To ensure that the sharing of patient information between providers is appropriate, timely, accurate and secure, effective data-sharing infrastructure needs to be developed. To optimise inter-hospital data-sharing for IBD patients, we need to better understand patterns of hospital encounters in this group.AIM To determine the type and location of hospital services accessed by IBD patients in England.METHODSThis was a retrospective observational study using Hospital Episode Statistics, a large administrative patient data set from the National Health Service in England.Adult patients with a diagnosis of IBD following admission to hospital were followed over a 2-year period to determine the proportion of care accessed at the same hospital providing their outpatient IBD care, defined as their ‘home provider'. Secondary outcome measures included the geographic distribution of patient-sharing, regional and age-related differences in accessing services, and type and frequency of outpatient encounters.RESULTS95055 patients accessed hospital services on 1760156 occasions over a 2-year follow-up period. The proportion of these encounters with their identified IBD‘home provider' was 73.3%, 87.8% and 83.1% for accident and emergency,inpatient and outpatient encounters respectively. Patients living in metropolitan centres and younger patients were less likely to attend their ‘home provider' for hospital services. The most commonly attended specialty services were gastroenterology, general surgery and ophthalmology.CONCLUSION Transitions of care between secondary care settings are common for patients with IBD. Effective systems of data-sharing and care integration are essential to providing safe and effective care for patients. Geographic and age-related patterns of care transitions identified in this study may be used to guide interventions aimed at improving continuity of care. | Leigh R Warren Jonathan M Clarke Sonal Arora Mauricio Barahona Naila Arebi Ara Darzi | 2019 | World Journal of Gastroenterology2019，25，17： | 1 |
| 17 | Effect of polyols and diisocyanares on thermo-mechanical and morphological properties of polyurearies显示文摘 | Sonal Desai Thakore I M Sara B D | 2000 | European Polymer Journal2000，36，： | 1 |
| 18 | Risk of pancreatic adverse events associated with the use of glucagon-like peptide-1 receptor agonist and dipeptidyl peptidase-4 inhibitor drugs: A systematic review and metaanalysis of randomized trials显示文摘AIM: To systematically assess risk of pancreatic adverse events with glucagon-like peptide-1(GLP-1) receptor agonist and dipeptidyl peptidase-4(DPP-4) inhibitor drugs.METHODS: We searched Pub Med, Embase, CINAHL, Cochrane review of clinical trials, pharmaceutical company clinical trials register, United States Food and Drug Administration website, European Medicines Agency website and Clinical Trials.gov for randomized controlled trials from inception to October 2013. Randomized control trial studies were selected for inclusion if they reported on pancreatic complication events and/or changes in pancreatic enzyme levels(serum amylase and serum lipase) as adverse events or as serious adverse events for patients who were on GLP-1 receptor agonist and DPP-4 inhibitor drugs. Two independent reviewers extracted data directly. We performed Peto odds ratio(OR) fixed effect meta-analysis of pancreatic adverse events a, and assessed heterogeneity with the I^2 statistic.RESULTS: Sixty-eight randomized controlled trials were eligible. A total of 60720 patients were included in our analysis of the association of risk of pancreatic complication events with GLP-1 agents. A total of 89 pancreatic related adverse events occurred among the GLP-1 agents compared to 74 events among the controls. There was a statistically significant increased risk of elevation of pancreatic enzymes associated with GLP-1 agents compared with control(Peto OR = 3.15, 95%CI: 1.56-6.39, P = 0.001, I2 = 0%). There was no statistically significant difference in the risk of pancreatic adverse event associated with GLP-1 agent compared with controls(Peto OR = 1.00, 95%CI: 0.73-1.37, P = 1.00, I2 = 0%). There were a total of 71 pancreatitis events in patients on GLP-1 agents and 56 pancreatitis events occurred in the control patients. There were 36 reports of pancreatic cancer in these studies. Of these cases, 2 used linagliptin, 2 used alogliptin, 1 used vildagliptin, 7 used saxagliptin while 6 used sitagliptin. The remaining 18 cases occurred among controls.CONCLUSION: Although GLP-1 based agents are associated with pancreatic enzyme elevation, we were unable to confirm a significant risk of pancreatitis or pancreatic cancer. | Hasan M Shihab Tokunbo Akande Kacie Armstrong Sonal Singh Yoon K Loke | 2015 | World Journal of Meta-Analysis2015，3，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员